CVS Health Corporation (NYSE:CVS) Stock Has Consensus Target Price of $109.64 According to Analysts

CVS Health Corporation (NYSE:CVS) has earned a consensus recommendation of “Moderate Buy” from the twenty-five ratings firms that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and twenty-two have issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is $108.25.

Several analysts have weighed in on CVS shares. Leerink Partners decreased their price objective on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating on the stock in a research note on Thursday. Wells Fargo & Company increased their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Weiss Ratings downgraded CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 9th. TD Cowen reissued a “buy” rating on shares of CVS Health in a research note on Wednesday. Finally, UBS Group dropped their price target on CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a research note on Thursday.

Insider Buying and Selling

In other CVS Health news, EVP Prem Shah bought 23,855 shares of the business’s stock in a transaction on Friday, November 6th. The stock was bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.85% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On CVS Health

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of CVS Health in the second quarter worth $12,747,462,000. State Street Corp grew its holdings in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. Bank of America Corp DE boosted its position in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC purchased a new position in shares of CVS Health during the second quarter valued at about $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $83.76 on Friday. CVS Health has a one year low of $69.51 and a one year high of $110.68. The company has a market capitalization of $107.12 billion, a price-to-earnings ratio of 9.75, a PEG ratio of 0.82 and a beta of 0.58. The stock has a 50-day moving average of $90.37 and a 200 day moving average of $88.89. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the firm posted $1.60 earnings per share. On average, sell-side analysts forecast that CVS Health will post 8.26 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is 30.97%.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.